Association between hypoglycemic agent use and the risk of occurrence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus

Nonalcoholic fatty liver disease (NAFLD) is a growing health concern with increasing prevalence and associated health impacts. Although no approved drugs are available for the NAFLD treatment, several hypoglycemic agents have been investigated as promising therapeutic agents. We aimed to compare the...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Choungwon, Park, Soyoung, Kim, Hyunah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664876/
https://www.ncbi.nlm.nih.gov/pubmed/37992029
http://dx.doi.org/10.1371/journal.pone.0294423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664876/
https://www.ncbi.nlm.nih.gov/pubmed/37992029
http://dx.doi.org/10.1371/journal.pone.0294423

Ejemplares similares